http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0386896-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c9446a65422eaca792040fe2b817fb5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate | 1990-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40de1748f84555f93395d29aa8d57f4a |
| publicationDate | 1991-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0386896-A |
| titleOfInvention | 3'-azido-3'-deoxy-5'-o-stearoylthymidine |
| abstract | NEW MATERIAL:3'-Azido-3'-deoxy-5'-O-stearoylthymidine. n USE: An antiviral agent capable of sustaining stable blood concentration and relieving toxicity derived from the blood concentration due to excellent in vivo sustained release. Time-dependent pharmacological effects can be exhibited to the maximum and high treating effects are provided. Since a low frequency of administration to patients is sufficient, compliance of the patients is improved. n PREPARATION: One mol 3'-azido-3'-deoxythymidine is reacted with a reactive derivative of stearic acid (e.g. stearoyl chloride) in a molar amount of 1-2 times in a solvent, such as THF, preferably at 0-10°C for 1-50hr. n COPYRIGHT: (C)1991,JPO&Japio |
| priorityDate | 1989-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.